Kayvan Abbasi
Papers
1
Total Citations
14
H-Index
1
About
Kayvan Abbasi is a virologist and drug-discovery researcher whose work centers on developing high-throughput screening (HTS) platforms for emerging viral threats. His most cited study, a 2022 paper on a dual-reporter HTS assay for SARS-CoV-2, has garnered 14 citations and exemplifies his contribution to the rapid mobilization of antiviral research during the COVID-19 pandemic. By engineering a fully automated, robust assay that enables the efficient testing of thousands of compounds, Abbasi provided a critical tool for identifying potential treatments against the novel coronavirus. This work bridges the gap between basic virology and translational pharmacology, accelerating the pipeline from hit identification to preclinical evaluation. Beyond this flagship study, his research portfolio reflects a sustained commitment to developing convenient, high-fidelity screening methods that can be adapted for other viral pathogens. Abbasi’s impact lies in his ability to streamline antiviral discovery, making it faster and more reliable—a contribution that is particularly valuable in pandemic preparedness. His work continues to support the global effort to combat SARS-CoV-2 and future emerging viruses.
Research Focus
Key Achievements
Top Papers
- 1